**Question:** Desmopressin is a synthetic analog of ADH. It is preferred over arginine vasopressin in the treatment of diabetes insipidus for all of the following reasons EXCEPT:

A. Desmopressin has a longer half-life than arginine vasopressin.
B. Desmopressin exerts a stronger antidiuretic effect than arginine vasopressin.
C. Desmopressin has a narrower therapeutic index than arginine vasopressin.
D. Desmopressin has a broader spectrum of action than arginine vasopressin.

**Correct Answer:** D. Desmopressin has a broader spectrum of action than arginine vasopressin.

**Core Concept:**
Desmopressin and arginine vasopressin are synthetic analogs of vasopressin, a hormone responsible for maintaining fluid balance in the body by regulating urine concentration and volume. Desmopressin is a longer-acting and more potent version of vasopressin, and is used to treat conditions like diabetes insipidus and central diabetes mellitus. Arginine vasopressin, on the other hand, is a shorter-acting and less potent version of vasopressin, and is used to treat conditions like hyponatremia and euvolemic hyponatremia.

**Why the Correct Answer is Right:**
Desmopressin's broader spectrum of action refers to its ability to mimic the effects of arginine vasopressin beyond regulating urine concentration and volume. One of its effects is to increase blood pressure, making it useful in treating central diabetes mellitus. This is not the case for arginine vasopressin, which primarily focuses on regulating urine concentration and volume.

**Why Other Options are Incorrect:**
A. Desmopressin has a longer half-life than arginine vasopressin is incorrect because the half-life refers to how long a medication remains active in the body. While it is true that desmopressin has a longer half-life, this is not the reason for its broader spectrum of action.

B. Desmopressin exerts a stronger antidiuretic effect than arginine vasopressin is partially correct, but not the reason for its broader spectrum of action. Although desmopressin is more potent than arginine vasopressin, the broader spectrum lies in its effects on blood pressure regulation, not urine production.

C. Desmopressin has a narrower therapeutic index than arginine vasopressin is incorrect because therapeutic index refers to the range between effective and toxic doses of a medication. While it is true that the therapeutic index of desmopressin is narrower than arginine vasopressin, this is not the reason for its broader spectrum of action.

D. Desmopressin has a lower affinity for V2 receptors than arginine vasopressin is partially correct, but does not address the broader spectrum of action. Although desmopressin has a lower affinity for V2 receptors, the broader spectrum lies in its effects on blood